State Street
COYA icon

State Street’s Coya Therapeutics COYA Stock Holding History

State Street’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Hold
79,813
– – ﹤0.01% 3611
2026
Q1 		$314K Buy
79,813
+10,303
+15% +$48.2K ﹤0.01% 3767
2025
Q4 		$403K Buy
69,510
+21,410
+45% +$130K ﹤0.01% 3735
2025
Q3 		$274K Hold
48,100
– – ﹤0.01% 3816
2025
Q2 		$277K Hold
48,100
– – ﹤0.01% 3748
2025
Q1 		$311K Hold
48,100
– – ﹤0.01% 3722
2024
Q4 		$276K Buy
48,100
+5,100
+12% +$34.7K ﹤0.01% 3776
2024
Q3 		$277K Hold
43,000
– – ﹤0.01% 3743
2024
Q2 		$261K Sell
43,000
-3,200
-7% -$25.7K ﹤0.01% 3745
2024
Q1 		$458K Buy
+46,200
New +$362K ﹤0.01% 3672

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street's COYA Position: Q2 2026 in Review

State Street held its Coya Therapeutics (COYA) position steady in Q2 2026 at 79,813 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

State Street first reported a position in COYA in Q1 2024 and has held it in 10 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • State Street held 79,813 shares of Coya Therapeutics worth $467K as of Q2 2026.
  • State Street left its Coya Therapeutics share count unchanged in Q2 2026.
  • Coya Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3611 holding.
  • State Street first reported a position in Coya Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.